Skip Nav Destination
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II
Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation
Hematopathologic and cytogenetic findings in imatinib mesylate–treated chronic myelogenous leukemia patients: 14 months' experience
Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy
Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis
Absence of biologically important Kaposi sarcoma–associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma
MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+precursors
Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura
The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings
Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura
Issue Archive
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
Characterization of a new subpopulation of mouse CD8α+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential
Pilar Martı́n,Gloria Martı́nez del Hoyo,Fabienne Anjuère,Cristina Fernández Arias,Héctor Hernández Vargas,Africa Fernández-L,Verónica Parrillas,Carlos Ardavı́n
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose
Clinical Trials & Observations
Cesare Guglielmi,William Arcese,Francesco Dazzi,Ronald Brand,Donald Bunjes,Leo F. Verdonck,Anton Schattenberg,Hans-Jochem Kolb,Per Ljungman,Agnes Devergie,Andrea Bacigalupo,Marta Gomez,Mauricette Michallet,Ahmet Elmaagacli,Alois Gratwohl,Jane Apperley,Dietger Niederwieser,on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
Clinical Trials & Observations
Stephanie J. Lee,John P. Klein,A. John Barrett,Olle Ringden,Joseph H. Antin,Jean-Yves Cahn,Matthew H. Carabasi,Robert Peter Gale,Sergio Giralt,Gregory A. Hale,Osman Ilhan,Philip L. McCarthy,Gerard Socie,Leo F. Verdonck,Daniel J. Weisdorf,Mary M. Horowitz
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial
Clinical Trials & Observations
Mary E. D. Flowers,Pablo M. Parker,Laura J. Johnston,Alice V. B. Matos,Barry Storer,William I. Bensinger,Rainer Storb,Frederick R. Appelbaum,Stephen J. Forman,Karl G. Blume,Paul J. Martin
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II
Clinical Trials & Observations
Maurizio Aricò,Maria Grazia Valsecchi,Valentino Conter,Carmelo Rizzari,Andrea Pession,Chiara Messina,Elena Barisone,Vincenzo Poggi,Giulio De Rossi,Franco Locatelli,Maria Concetta Micalizzi,Giuseppe Basso,Giuseppe Masera,for the Associazione Italiana di Ematologia ed Oncologia Pediatrica
Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation
Clinical Trials & Observations
Dorothy R. Barnard,Beverley Lange,Todd A. Alonzo,Jonathan Buckley,J. Nathan Kobrinsky,Stuart Gold,Steven Neudorf,Jean Sanders,Laura Burden,William G. Woods
Hematopathologic and cytogenetic findings in imatinib mesylate–treated chronic myelogenous leukemia patients: 14 months' experience
Clinical Trials & Observations
Rita M. Braziel,Teresa M. Launder,Brian J. Druker,Susan B. Olson,R. Ellen Magenis,Michael J. Mauro,Charles L. Sawyers,Ronald L. Paquette,Michael E. O'Dwyer
Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy
Clinical Trials & Observations
Karen K. Ballen,Pamela S. Becker,Robert V. B. Emmons,Thomas J. Fitzgerald,Chung C. Hsieh,Qin Liu,Christine Heyes,Yeteive Clark,William Levy,Jean Francois Lambert,Frank Chiafari,Irma Szymanski,Sarah Rososhansky,Mark A. Popovsky,F. Marc Stewart,Peter J. Quesenberry
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils
Johann Wojta,Christoph Kaun,Gerlinde Zorn,Minoo Ghannadan,Alexander W. Hauswirth,Wolfgang R. Sperr,Gerhard Fritsch,Dieter Printz,Bernd R. Binder,Georg Schatzl,Joerg Zwirner,Gerald Maurer,Kurt Huber,Peter Valent
IMMUNOBIOLOGY
NEOPLASIA
Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH)
Nicole Dastugue,Marina Lafage-Pochitaloff,Marie-Pierre Pagès,Isabelle Radford,Christian Bastard,Pascaline Talmant,Marie Joelle Mozziconacci,Claude Léonard,Christelle Bilhou-Nabéra,Christine Cabrol,Anne-Marie Capodano,Pascale Cornillet-Lefebvre,Michel Lessard,Francine Mugneret,Christine Pérot,Sylvie Taviaux,Odile Fenneteaux,Eliane Duchayne,Roland Berger,on behalf of the Groupe Français de Cytogénétique Hématologique (GFCH) and with the contribution of the Groupe Français d'Hématologie Cellulaire (GFHC)
Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts
Andy C. Rawstron,Michael J. Green,Anita Kuzmicki,Ben Kennedy,James A. L. Fenton,Paul A. S. Evans,Sheila J. M. O'Connor,Stephen J. Richards,Gareth J. Morgan,Andrew S. Jack,Peter Hillmen
RED CELLS
TRANSFUSION MEDICINE
TRANSPLANTATION
BRIEF REPORTS
Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis
Clinical Trials & Observations
Brief Report
Daniel F. Wallace,Palle Pedersen,Jeannette L. Dixon,Peter Stephenson,Jeffrey W. Searle,Lawrie W. Powell,V. Nathan Subramaniam
Absence of biologically important Kaposi sarcoma–associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma
Brief Report
Christian Brander,Noopur Raje,Paula G. O'Connor,Faith Davies,Jennifer Davis,Darminder Chauhan,Teru Hideshima,Jeff Martin,Dennis Osmond,Dean H. Kedes,Bruce D. Walker,David T. Scadden,Kenneth C. Anderson
MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+precursors
Brief Report
Allan J. Masterson,Claudia C. Sombroek,Tanja D. de Gruijl,Yvo M. F. Graus,Hans J. J. van der Vliet,Sinéad M. Lougheed,Alfons J. M. van den Eertwegh,Herbert M. Pinedo,Rik J. Scheper
Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura
Clinical Trials & Observations
Brief Report
The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia
Brief Report
Luciana Teofili,Francesco Pierconti,Annalaura Di Febo,Nicola Maggiano,Nicola Vianelli,Stefano Ascani,Elena Rossi,Stefano Pileri,Giuseppe Leone,Luigi Maria Larocca,Valerio De Stefano
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings
Clinical Trials & Observations
Brief Report
Alvaro Urbano-Ispizua,Ciril Rozman,Pedro Pimentel,Carlos Solano,Javier de la Rubia,Salut Brunet,Jaime Pérez-Oteyza,Christelle Ferrá,Javier Zuazu,Dolores Caballero,Joan Bargay,Alzira Carvalhais,Jose Luis Dı́ez,Ildefonso Espigado,Adrián Alegre,Montserrat Rovira,Fernando Campilho,Jesús Odriozola,Miguel Angel Sanz,Jordi Sierra,Javier Garcı́a-Conde,Emili Montserrat
Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura
Clinical Trials & Observations
Brief Report
CORRESPONDENCE
Pregnancies after high-dose chemotherapy and autologous stem cell transplantation in aggressive lymphomas
Pauline Brice,Corinne Haioun,Marc André,Christian Gisselbrecht,for the Groupe d'Etude des Lymphomes de l'Adulte
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals